BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Liver
,
Amniocentesis
,
Fluoxetine
,
rs4950928
,
PRKCA
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tumour suppressors
Summary
General Info
Curated Studies
Most Correlated Studies
BRD7 is a candidate tumour suppressor gene required for p53 function
Drosophila embryonic gene expression regulated by the tumor suppressor gene Wwox
Renal carcinoma derived cell lines following 5-Aza-2-deoxycytidine (AZA) treatment
Primary ependymoma cell cultures treated with 5-aza-2-deoxycytidine
Comparison of Melanoma cells with different oncogenic mutations
Explore Curated Studies Results
Literature
Most Relevant Literature
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
In silico analysis prediction of HepTH1-5 as a potential therapeutic agent by targeting tumour suppr…
SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.
The Drosophila tumour suppressor Lgl and Vap33 activate the Hippo pathway through a dual mechanism.
Correlations between histological characterizations and methylation statuses of tumour suppressor ge…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases
Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer
Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppr…
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ